Onvansertib + Paclitaxel In TNBC

Clinical trial NCT05383196 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05383196
Sponsor: Antonio Giordano, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Invasive Breast Cancer Unresectable Breast Carcinoma Locally Advanced Breast Cancer Metastatic Breast Cancer Inflammatory Breast Cancer Triple Negative Breast Cancer (TNBC)Hormone Receptor/Growth Factor Receptor-Negative Breast Cancer HER2-negative Breast Cancer Hormone Receptor Negative Breast Carcinoma

Start date: 2022-09-30
Primary completion: 2026-12-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.